Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to
worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting
immunostaining in relation to complex human pathologies.
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding.
Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
FXR1 antibody was raised against synthetic peptide C-RIEGDNENKLPRED from an internal region of human FXR1 (NP_005078.2; NP_001013456.1; NP_001013457.1). Percent identity by BLAST analysis: Human, Gorilla, Orangutan, Gibbon, Monkey, Marmoset, Mouse, Rat, Hamster, Elephant, Panda, Dog, Bat, Bovine, Horse, Rabbit, Pig, Opossum, Turkey, Chicken, Platypus, Lizard (100%); Xenopus (93%).
LS-E26145 - Lyophilized - 100 µg - $145.00
Immunizing peptide used to generate LS-C34682. Useful for pre-absorption and neutralization of the antibody's antigen binding site.
Human FXR1. This antibody is expected to recognise all reported isoforms (NP_005078.2, NP_001013456.1 and NP_001013457.1).
Peptide ELISA: antibody detection limit dilution 1:128000. Western blot: Approx 80 kDa band observed in lysates of cell line NIH/3T3 (calculated MW of 59.9 kDa according to NP_001013457.1). The observed molecular weight corresponds to earlier findings in literature with different antibodies (Khandjian et al Hum Mol Genet. 1998 Dec;7(13):2121-8.; PMID: 9817930). Recommended concentration: 0.1-0.3 ug/ml.